Evidence map›Paper›PMID 37934903›Full record

ReviewExpert review of anti-infective therapy

Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis.

Weiping Cao, Phoebe G Thorpe, Kevin O'Callaghan, Ellen N Kersh

Registry-linked trialAbstract readReview
In one paragraph

Review in Expert review of anti-infective therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07358949 (Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07358949 not yet recruitingnot on this map

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

TypeobservationalSponsorQueen's Medical CenterRan2026 to 2027Enrolled70ConditionsSyphilis InfectionArmsRapid Syphilis Test
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Detection ofMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Update on syphilis diagnostics.Current opinion in infectious diseases · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weiping CaoDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Phoebe G ThorpeDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kevin O'CallaghanDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ellen N KershDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

introductionThe reemergence of syphilis, especially congenital syphilis, presents a significant public health threat. Accurate diagnosis of syphilis depends on recognition of a constellation of symptoms, review of medical and sexual history, and multiple laboratory tests. While reliable, current tests for syphilis can be difficult to interpret, which can lead to delays in treatment. AREA COVERED: This review summarizes the major advantages and limitations of available diagnostic laboratory methods for syphilis, provides an update on recent advances in laboratory tools, and highlights the urgent need for coordinated efforts to create new tools to halt the resurgence of syphilis. EXPERT OPINION: In syphilis, the wide variety of short-lived signs and symptoms followed by periods of latency create diagnostic challenges. Currently available laboratory tests, when positive, require additional information to interpret (prior testing, treatment, and sexual history). Point-of-care tests that can rapidly and accurately detect both treponemal and non-treponemal antibodies would be a huge step toward reducing test turnaround time and time to treatment. Incorporating biological insights and technology innovations to advance the development of direct detection assays is urgently needed. A comprehensive coordinated effort is critical to stem the tide of rising syphilis in the United States and globally.

Indexed as

SyphilisSyphilis, CongenitalAntibodies, BacterialHumansSensitivity and SpecificitySyphilis SerodiagnosisTreponema pallidumAntibodies, BacterialCongenital syphilismolecular detectionnontreponemal testserologic testsyphilissyphilis screeningtreponemal testtreponema pallidum

Identifiers

PMID37934903
PMCPMC10958575
OpenAlexW4388450099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.